ERLOCIP (Erlotinib or Tarceva) is monotherapy treatment for advanced or metastatic non-small cell lung cancer 150 mg once daily. Erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. For more : http://www.healthcare247.co/category/cancer-therapy
Report
Other Formats
Download
Commentaires
Ajouter un commentaire
S'il vous plaît connectez-vous pour pouvoir ajouter des commentaires !